Skip to main content
    Find Your Path
    Medicare News

    Why Is 2027 Medicare Part D Costing More?

    The deductible rises to $700 and the cap to $2,400 — but the federal premium subsidy ending December 31 is the bigger change, and 2027 premiums are now out.

    Share:
    Paired bar chart: Part D annual deductible rises from $615 in 2026 to $700 in 2027, and the out-of-pocket cap from $2,100 to $2,400, with the increase portion highlighted. Source: CMS Part D benefit parameters
    Updated November 11, 2026
    Advertisement
    In this article7
    1. 01What's confirmed for 2027
    2. 02Why the deductible jumped almost 14%
    3. 03The bigger story: the premium subsidy ends December 31
    4. 04What is not changing in 2027
    5. 05Negotiated drug prices arrive January 1
    6. 06How the three phases work in 2027
    7. 07What to do, and when

    📋Quick Summary

    • The standard Part D deductible rises to $700 in 2027, up from $615 — a 13.8% increase.
    • The annual out-of-pocket cap rises to $2,400, up from $2,100 — a 14.3% increase.
    • A federal program holding standalone drug plan premiums down ends December 31, 2026.
    • The $35 insulin cap, $0 recommended vaccines, Extra Help, and the payment plan option all continue unchanged.
    • 2027 premiums are out: CMS projects a $36 average for stand-alone drug plans, while KFF projects $51 and finds most enrollees without Extra Help would pay more if they keep their plan.

    Two separate things are pushing Part D costs up in 2027, and they get confused constantly because they landed months apart.

    The first is routine: the deductible and out-of-pocket cap go up every year under a formula in the law. For 2027 they're $700 and $2,400.

    The second is not routine. On July 28, 2026, CMS announced it is ending a temporary program that has been holding down premiums on standalone drug plans since 2025. That program is gone as of January 1, 2027, and plans' 2027 premiums now show the effect.

    Here's how to think about both. For everything else changing next year, see our complete guide to 2027 Medicare changes, and for the rules side of 2027 — why your 2027 Medicare sales call could come faster now.

    What's confirmed for 2027

    These figures apply to the defined standard benefit — the legal minimum a plan may offer. Many plans set a lower deductible or structure their benefit differently, so treat these as the outer boundary, not a prediction of your plan.

    Part D standard benefit: 2026 vs. 2027
    20262027Change
    Standard deductible$615$700+$85 (13.8%)
    Out-of-pocket cap$2,100$2,400+$300 (14.3%)
    Base beneficiary premium$38.99$41.33+$2.34 (6.0%)
    National average bid amount$239.27$296.05+23.7%

    Two of those rows deserve a warning label. The base beneficiary premium is a statutory starting point used to calculate what each plan may charge — it is not your premium. The national average bid amount is an enrollment-weighted average of plan bids used to set the federal subsidy. Nobody pays either number. They get misreported as premiums every single year.

    Why the deductible jumped almost 14%

    The 2026 deductible rose about 4% over 2025. The 2027 increase is more than three times that. The reason is mechanical rather than political.

    Congress tied both the deductible and the out-of-pocket cap to the annual percentage increase in average per-capita Part D spending — not to general inflation, and not to the Social Security COLA. When per-enrollee drug spending accelerates, these thresholds accelerate with it. CMS actuaries projected faster growth for 2027, so both numbers moved sharply.

    The practical consequence: if you take ongoing brand-name or specialty medications, you will reach the point where your drugs cost $0 later in the calendar year than you did in 2026, and you'll pay more before you get there.

    Advertisement
    ⚡ 📌 A Higher Cap Is Not Weaker Protection

    Before 2025 there was no ceiling at all on Part D out-of-pocket spending. A specialty drug could run five figures a year with no stopping point. $2,400 is a worse ceiling than $2,100 — and still a categorically different world from no ceiling.

    The bigger story: the premium subsidy ends December 31

    When the Inflation Reduction Act capped out-of-pocket spending, it shifted a large share of catastrophic drug costs from Medicare onto the insurers running Part D plans. Facing a benefit structure they had never priced before, insurers proposed steep premium increases — particularly on standalone drug plans, the kind people on Original Medicare buy alongside a Medigap policy.

    → Medigap supplement plans

    To prevent that, CMS created the Part D Premium Stabilization Demonstration for the 2025 plan year. It worked two ways: it reduced the base beneficiary premium used in plan pricing, and it capped how much any single plan's premium could rise year over year.

    What the demonstration did
    Plan yearBase premium reductionMax allowed premium increase
    2025$15$35
    2026$10$50
    2027None — program endedNo cap

    The program cost about $9.8 billion across 2025 and 2026, according to the Government Accountability Office. CMS's stated rationale for ending it is that after reviewing 2027 bids, plan sponsors now have enough experience with the redesigned benefit to price without it.

    How much more will you actually pay?

    This is where sources diverge, and you should know that going in.

    CMS Administrator Dr. Mehmet Oz wrote in July that most people with Medicare will pay less than $10 more in premiums next year. In September, CMS projected the average stand-alone drug plan premium at $36 a month in 2027, up from $35.09.

    KFF's analysis of the actual 2027 plans is less reassuring. It projects the average stand-alone premium at $51 in 2027, up from $34, and finds that 10.4 million of the 13.6 million stand-alone enrollees without Extra Help — 76% — would pay more if they keep their current plan, 2.4 million of them by more than $50 a month. KFF found 24% would see a reduction.

    → If your 2027 plan is cancelled

    Earlier, a GAO analysis found that monthly premiums would have roughly doubled on average for people who stayed in the same plan from 2024 to 2025 without the subsidy. The effect is uneven by plan and by region, which is why your own plan's Annual Notice of Change and a Plan Finder comparison matter more than any average. Our breakdown of 2027 drug plan premiums shows how the major national plans changed.

    ⚡ ⚠️ Who Is Most Exposed

    People on Original Medicare with a standalone Part D plan — 24.9 million enrollees in 2026 — and especially the 13.6 million of them without Extra Help. If you have Medicare Advantage with drug coverage built in, this change largely does not reach you.

    What is not changing in 2027

    The July announcement produced a wave of alarming headlines. To be clear about what survives intact:

    • The out-of-pocket cap itself. It rises to $2,400 but it is not going anywhere. Hit it and covered drugs cost you $0 for the rest of the year.
    • The $35 insulin cap. Continues for a month's supply of each covered insulin, with no deductible.
    • $0 recommended adult vaccines. Continues, and remains exempt from the deductible.
    • Extra Help (the Low-Income Subsidy). Continues.
    • No coverage gap. The donut hole was eliminated in 2025 and stays eliminated.
    • The Medicare Prescription Payment Plan. Still available, and CMS adopted automatic renewal for the next year unless you opt out.
    Advertisement

    Negotiated drug prices arrive January 1

    Working in the other direction: the second round of Medicare-negotiated prices takes effect January 1, 2027, covering 15 more Part D drugs. Prices are 38% to 85% below 2024 list prices.

    The headline is semaglutide — Ozempic, Rybelsus, and Wegovy — at $274 for a 30-day supply, compared with a $959 list price in 2024, a 71% cut. Whether Part D covers it for weight loss is a separate question; our Ozempic and Wegovy 2027 guide explains the coverage rules.

    One caution that gets lost in the coverage: a negotiated price is what Medicare and your plan pay the manufacturer. Your copay depends on your plan's design, your tier, and which benefit phase you're in. A 71% cut to the negotiated price does not mean a 71% cut at your counter.

    How the three phases work in 2027

    Part D runs in three stages now, not four:

    1. Deductible. You pay 100% of covered drug costs until you hit your plan's deductible — up to $700 under the standard benefit.
    2. Initial coverage. You and your plan share costs. Under the standard benefit that's 25% coinsurance.
    3. Catastrophic. Once your true out-of-pocket spending reaches $2,400, you pay $0 for covered drugs for the rest of the calendar year.

    Worth knowing: your deductible spending counts toward the $2,400.

    What to do, and when

    2027 Part D calendar
    DateWhat happens
    By Sept 30, 2026Annual Notice of Change sent (done)
    Sept 28, 2026CMS published 2027 premium projections (done)
    Oct 1, 20262027 plan data live in Medicare Plan Finder (done)
    Oct 15 – Dec 7Annual Enrollment Period
    Jan 1, 2027New pricing and negotiated drug prices take effect

    Your Annual Notice of Change answers the question this article can't: what your specific plan will cost. Three things to check in it — your premium, whether your prescriptions are still on the formulary, and whether any of them moved to a higher tier or picked up a prior authorization requirement. Then compare in Medicare.gov's Plan Finder before December 7.

    ✅The Bottom Line

    The deductible and cap increases are locked in and modest in absolute terms. The premium subsidy ending is the change worth your attention, and it lands hardest on people with Original Medicare and a standalone drug plan who don't get Extra Help. The 2027 numbers are out now. Compare plans before December 7 rather than letting yours auto-renew — in a year like this one, auto-renewal is the expensive default.

    Sources

    1. Medicare Part D Premiums and Cost Sharing in 2027 — KFF (Juliette Cubanski, Meredith Freed, Nancy Ochieng), Oct 30, 2026
    2. 8 Changes Coming to Medicare in 2027 — Kiplinger (Donna LeValley), Sep 3, 2026
    3. Medicare Part D 2027 National Average Monthly Bid Amount Information — CMS, Jul 28, 2026
    4. 2026 Medicare Part D Bid Information and Part D Premium Stabilization Demonstration Parameters — CMS, Jul 28, 2025
    5. CMS's Decision to End Temporary Subsidies to Medicare's Stand-Alone Drug Plans Could Mean Larger Premium Increases for Some Beneficiaries Next Year — KFF (Juliette Cubanski), Jul 29, 2026
    6. The Trump administration's move to end subsidies for Medicare drug plans could cost consumers — NPR (Sydney Lupkin), via Michigan Public, Jul 29, 2026
    7. CMS to end subsidies for Medicare drug plan premiums — Healthcare Dive (Emily Olsen), Jul 29, 2026
    8. Medicare Advantage and Medicare Prescription Drug Programs Expected to Remain Stable in 2027 — CMS, Sep 28, 2026
    9. Insulin — Medicare.gov, Undated, accessed Nov 11, 2026
    10. Shingles vaccines — Medicare.gov, Undated, accessed Nov 11, 2026
    11. Contract Year 2026 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Final Rule — CMS, Apr 4, 2025
    12. Medicare Drug Price Negotiation Program: Negotiated Prices for Initial Price Applicability Year 2027 — CMS, Undated, accessed Nov 11, 2026
    13. Catastrophic coverage — Medicare.gov, Undated, accessed Nov 11, 2026
    Share this article:

    Not Sure Where You Fit?

    Find Your Medicare Path in 6 Questions

    Answer 6 short questions to see which Medicare deadlines, costs and IRMAA rules apply to you in 2027. Free, and no email needed.

    Start the 6-question check